Magnetic susceptibility
Showing 1 - 25 of 9,232
Visibility of Venous Network in Magnetic Susceptibility Imaging
Active, not recruiting
- Stroke
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Dec 30, 2021
Longitudinal Quantitative Susceptibility Mapping in Alzheimer 's
Enrolling by invitation
- Alzheimer's Disease
- MRI
- (no location specified)
Aug 24, 2022
Thrombus in Acute Ischemic Stroke.
Completed
- Acute Ischemic Stroke
- Magnetic resonance imaging
-
Bharatpur, Bagmati, NepalSushanta Paudel
Feb 17, 2023
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Early Postprocedural Susceptibility-Weighted Imaging and
Recruiting
- Early Susceptibility-Weighted Imaging and Vessel-Wall Imaging Findings After Flow-Diversion Treatment of Intracranial Aneurysms
- Pre-procedural, early and late post-procedural susceptibility weighted imaging and vessel wall imaging with a 3T Magnetic Resonance Imaging Device
- +2 more
-
Bursa, Nilufer, TurkeyBursa Uludag University Faculty of Medicine Department of Radiol
Jan 29, 2023
Quantitative Susceptibility Mapping to Guide Iron Chelating
Recruiting
- MRI Scans
- Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI)
- R2* Magnetic Resonance Imaging (MRI)
-
New York, New York
- +1 more
Jan 19, 2022
MRI QSM Imaging for Iron Overload
Recruiting
- Hemochromatosis
- Iron Overload
- Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
-
Stanford, California
- +1 more
Aug 2, 2022
Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,
Completed
- Glioblastoma
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Columbus, Ohio
- +1 more
Mar 11, 2022
Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Completed
- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022
Brain Metastases, Radiosurgery Trial in Seoul (Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling
Not yet recruiting
- Brain Metastases
- Radiosurgery
- Magnetic resonance imaging (MRI)
- +3 more
-
Seoul, Korea, Republic ofAsan Medical Center
May 11, 2023
Brain Imaging in Cerebral Venous Outflow Disturbance
Recruiting
- Abnormal Cerebral Venous Sinus Morphology
- +2 more
- high-resolution 3D-T1
- +4 more
-
Beijin, XI Cheng District, ChinaXuanwu hospital;Capital Medical University
Apr 14, 2023
Brain Tumor, Brain Metastases Trial in Toronto (Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI))
Recruiting
- Brain Tumor
- Brain Metastases
- Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)
-
Toronto, Ontario, CanadaUniversity Health Network
May 2, 2022
Brain Tumors by Advanced MRI
Completed
- Glioblastoma
- Avastin
- +5 more
-
Boston, MassachusettsMassachusetts general Hospital
Apr 6, 2022
Invasive Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Atlanta (Dynamic Susceptibility Contrast-MRI
Recruiting
- Invasive Malignant Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Dynamic Susceptibility Contrast-MRI (DSC-MRI)
- Magnetic Resonance Imaging (MRI)
-
Atlanta, Georgia
- +1 more
Sep 1, 2021
Metastatic Malignant Tumor in the Brain, Primary Brain Tumor Trial in Portland (3 Tesla Magnetic Resonance Imaging, Dynamic
Terminated
- Metastatic Malignant Neoplasm in the Brain
- Primary Brain Neoplasm
- 3 Tesla Magnetic Resonance Imaging
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 3, 2021
Glioblastoma Trial in Saint Louis (device, drug, other)
Completed
- Glioblastoma
- MRI-guided Laser Heat Ablation (MLA)
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 26, 2021
Measurement of QSM Signal (Quantitative Susceptibility Mapping)
Recruiting
- White Matter Hyperintensity
- Multiple Sclerosis
- MRI
-
Paris, FranceHhopital fondation adolphe de rothschild
Aug 11, 2022
Breast Cancer Trial in Sittard (Pintuition)
Active, not recruiting
- Breast Cancer
- Pintuition
-
Sittard, Limburg, NetherlandsZuyderland Medical Center
Sep 19, 2023
Anti-angiogenic Treatment in Recurrent Glioblastoma
Recruiting
- Adult Glioblastoma
- +2 more
- 3-Tesla conventional magnetic resonance imaging
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 6, 2020
How Habitats Created by MRI Can Predict IDH Mutation Status and
Recruiting
- High-grade Glioma
-
Chongqing, Chongqing, ChinaDepartment of Radiology, Daping Hospital of Army Medical Univers
Aug 1, 2022
Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T
Recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- MRI scanner (7 Tesla)
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022
Post COVID-19, Cognitive Dysfunction Trial in Pomona (Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve
Active, not recruiting
- Post COVID-19
- Cognitive Dysfunction
- Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS)
-
Pomona, CaliforniaCasa Colina Hospital and Centers for Healthcare
Dec 26, 2022
Pathophysiology of Gilles de la Tourette Syndrome. Part 1:
Not yet recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- PET/MR scanner
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022
Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)
Recruiting
- Multiple Sclerosis
- 18F-florbetaben PET/CT
-
Pavia, PV, ItalyICS Maugeri SpA SB IRCCS
Mar 23, 2023